PPARα has neuroprotective effects in many disease models including cerebral ischemia/reperfusion, traumatic brain and spinal cord injury, Parkinson's disease, Alzheimer's disease, peripheral neuropathy, ischemic retinopathy, and DR (Table 1). The gene discussed is PPARA; the disease is early-onset autosomal dominant Alzheimer disease.